Reporting performance – non-financial1
ASTRAZENECA EMPLOYEES: ACCIDENTS WITH SERIOUS INJURY2 (PER MILLION HOURS) |
|---|
 |
 |
 |
ASTRAZENECA EMPLOYEES: CASES OF OCCUPATIONAL ILLNESSES (PER MILLION HOURS) |
|---|
 |
 |
 |
SALES AND MARKETING: NUMBER OF CONFIRMED BREACHES3 |
|---|
 |
 |
 |
NUMBER OF ANIMALS USED IN RESEARCH ’000 |
|---|
 |
 |
 |
GLOBAL WARMING POTENTIAL - EMISSIONS4
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| CO2-equivalents (million tonnes) | 1.29 | 1.31 | 1.43 |
| Index (tonnes/$m sales) | 44 | 50 | 60 |
OZONE DEPLETION POTENTIAL - EMISSIONS
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| CFC11-equivalents (tonnes) | 36 | 40 | 56 |
| Index (kg/$m sales) | 1.2 | 1.5 | 2.3 |
1Data excludes MedImmune.
2With and without days lost.
3Of codes or regulations ruled by external bodies.
4Figures are calculated in line with the Greenhouse Gas (GhG) Protocol guidance (ghgprotocol.org). Source for calculation of CFC figures is AstraZeneca sales data.
